专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US11757132B2 Non-aqueous electrolyte for lithium-ion battery and lithium-ion battery 有权
公开(公告)号：US11757132B2
公开(公告)日：2023-09-12
申请号：US17735109
申请日：2022-05-02
申请人： SHENZHEN CAPCHEM TECHNOLOGY CO., LTD.
发明人： Qiao Shi , Muchong Lin , Shiguang Hu , Xionggui Lin , Jiaojiao Yun , Chang'an Zeng
IPC分类号： H01M10/0567 , H01M10/0525 , H01M10/0569 , H01M10/056 , C07D327/10 , C07D317/10 , C07F9/06 , C07F9/113
CPC分类号： H01M10/0567 , C07D317/10 , C07D327/10 , C07F9/062 , C07F9/113 , H01M10/056 , H01M10/0525 , H01M10/0569 , H01M2300/0037
摘要： A non-aqueous electrolyte for a lithium-ion battery and a lithium-ion battery. The non-aqueous electrolyte includes an unsaturated phosphate compound and a cyclic unsaturated carboxylic anhydride compound. The unsaturated phosphate compound has a structure represented by structural formula (4). R13, R11 and R12 are each independently selected from a hydrocarbon group having 1 to 5 carbon atoms, and at least one of R13, R11 and R12 is an unsaturated hydrocarbon group having a double bond or a triple bond. The unsaturated cyclic carboxylic anhydride compound having a structure represented by Structural Formula 5. R14 is selected from the group consisting of an alkenylene group having 2 to 4 carbon atoms or a fluorinated alkenylene group having 2 to 4 carbon atoms. By means of the synergistic effect of two compounds, the non-aqueous electrolyte has excellent high-temperature cycling performance and storage performance, and also has lower impedance and good low-temperature performance.

2. 发明授权

US5025098A Method of preparing bicyclic tetrahydroxylated pyrrolizidines 失效
公开(公告)号：US5025098A
公开(公告)日：1991-06-18
申请号：US586916
申请日：1990-09-24
申请人： George W. J. Fleet
发明人： George W. J. Fleet
IPC分类号： C07D317/10 , C07D491/04 , C07D491/22 , C07D493/04
CPC分类号： C07D491/04 , C07D317/10 , C07D493/04
摘要： Novel bicyclic tetrahydroxylated pyrrolizidines are disclosed which are inhibitors of glycosidase enzymes. A preferred inhibitor is 1.alpha.,2.alpha.,6.alpha.,7.alpha.,7.alpha..beta.-1,2,6-7-tetrahydroxypyrrolizidine. It is synthesized from D-glycero-D-gulo-heptono-1,4-lactone.

3. 发明授权

US07160907B2 Pleuromutilin derivatives 失效
标题翻译： Pleuromutilin衍生物
公开(公告)号：US07160907B2
公开(公告)日：2007-01-09
申请号：US11004751
申请日：2004-12-03
申请人： John Stephen Elder , Andrew Keith Forrest , Richard Lewis Jarvest , Robert John Sheppard
发明人： John Stephen Elder , Andrew Keith Forrest , Richard Lewis Jarvest , Robert John Sheppard
IPC分类号： A01N43/40 , A61K31/41
CPC分类号： C07D331/04 , C07C271/66 , C07C2601/10 , C07C2603/82 , C07D205/04 , C07D207/12 , C07D207/16 , C07D207/22 , C07D207/26 , C07D207/273 , C07D207/404 , C07D211/42 , C07D211/46 , C07D213/30 , C07D213/40 , C07D213/64 , C07D231/22 , C07D239/30 , C07D239/42 , C07D239/49 , C07D239/54 , C07D261/12 , C07D263/24 , C07D265/30 , C07D295/185 , C07D295/26 , C07D307/20 , C07D307/66 , C07D317/10 , C07D319/06 , C07D333/32 , C07D401/06 , C07D493/04
摘要： Pleuromutilin compounds of the formula: are of use in anti-bacterial therapy.
摘要翻译：具有下列公式的Pleuromutilin化合物：用于抗菌治疗。

4. 发明授权

US2110499A Depolymebizatiqn 失效
公开(公告)号：US2110499A
公开(公告)日：1938-03-08
申请号：US2110499D
CPC分类号： C07D321/06 , C07D317/10 , C07D319/06

5. 发明申请

US20150291548A1 OCTAHYDRO BINAPHTHYL-BASED CHIRAL COMPOUND-CONTAINING LIQUID-CRYSTAL COMPOSITION AND OPTICAL ELEMENT 有权
标题翻译： OCTAHYDRO BINAPHTHYL-BASED CHIRAL复合液体水晶组合物和光学元件
公开(公告)号：US20150291548A1
公开(公告)日：2015-10-15
申请号：US14649917
申请日：2013-12-12
申请人： JNC CORPORATION , JNC PETROCHEMICAL CORPORATION
发明人： KOKI SAGO , SHIN-ICHI YAMAMOTO
IPC分类号： C07D317/10 , G02F1/137 , C09K19/54 , C09K19/58 , C07D239/26 , C09K19/34
CPC分类号： C07D317/10 , C07D239/26 , C07D309/04 , C07D317/12 , C07D319/06 , C07D321/00 , C07D405/12 , C07D407/12 , C07D493/18 , C09K19/20 , C09K19/34 , C09K19/542 , C09K19/586 , C09K19/588 , C09K2019/0411 , C09K2019/0466 , C09K2019/323 , C09K2019/325 , C09K2019/3422 , C09K2019/3427 , C09K2019/343 , C09K2019/3433 , G02F1/137 , G02F2001/13793
摘要： A liquid-crystal composition is composed of at least one chiral compound represented by general formula (K1) or (K2) and at least one achiral liquid-crystal component: (wherein, in formulas (K1) and (K2), Rk1 is, for example, alkyl having 1 to 5 carbons, Rk2 is, for example, alkyl having 1 to 20 carbons, ring Ak1 is, for example, 1,4-phenylene, Xk1 is, for example, a single bond, Yk1 is, for example, —(CH2)n—, n is an integer from 0 to 20, Zk1 is, for example, a single bond, mk1 is, for example, an integer from 2 to 4, and nk1 and nk2 are, for example, an integer from 0 to 2).
摘要翻译：液晶组合物由至少一种由通式（K1）或（K2）表示的手性化合物和至少一种非手性液晶组分组成：其中，在式（K1）和（K2）中，Rk1为，例如可以举出碳原子数1〜5的烷基，R k2例如为碳原子数1〜20的烷基，环Ak1为例如1,4-亚苯基，Xk1为单键，Yk1为例如， - （CH 2）n - ，n为0〜20的整数，Z k为例如单键，mk1为例如2〜4的整数，nk1和nk2为例如， 0到2之间的整数）。

7. 发明授权

US5068243A Bicyclic tetrahydroxypyrrolizidine 失效
标题翻译：双环四羟基吡咯烷啶
公开(公告)号：US5068243A
公开(公告)日：1991-11-26
申请号：US564009
申请日：1990-08-07
申请人： George W. J. Fleet
发明人： George W. J. Fleet
IPC分类号： C07D317/10 , C07D487/04 , C07D491/04 , C07D491/22 , C07D493/04 , C07F7/18
CPC分类号： C07D487/04 , C07D317/10 , C07D491/04 , C07D493/04 , C07F7/1856 , Y02P20/55
摘要： Novel bicyclic tetrahydroxylated pyrrolizidines are disclosed which are inhibitors of glycosidase enzymes. A preferred inhibitor is (1S,2R,6R,7S)-1,2,6,7-tetrahydroxypyrrolizidine. It is synthesized from D-glycero-D-talo-heptono-1,4-lactone and utilizes the novel intermediate compounds, 7-O-tert-butyldiphenylsilyl-2,3:5,6-di-O-isopropylidene-D- glycero-D-talo-heptono-1,4-lactone and (1S,2R,6R,7S)-1,2:6,7-di-O-isopropylidene-1,2,6,7-tetrahydroxypyrrolizidine, as follows:a) reacting D-glycero-D-talo-heptono-1,4-lactone with 2,2-dimethoxypropane to provide a fully protected lactone,b) selectively removing the acetonide group at C-6,7 to give a C-2,3 protected heptonolactone,c) reacting the C-2,3 protected lactone with a silyl blocking agent to protect the primary hydroxyl group and give a C-2,3,7 protected lactone,d) reacting the protected lactone with 2,2-dimethoxypropane to provide a fully protected lactone,e) reacting the fully protected lactone with fluoride ion to cleave at C7 and thereby provide access to nitrogen in the ring and give a primary alcohol,f) esterifying the primary alcohol with triflic anhydride to afford a triflate,g) reacting the triflate with azide ion to give an azidolactone,h) reducing the azidolactone to give an azidodiol,i) reacting the azidodiol with methanesulfonyl chloride to provide an axidodimesylate,j) catalytically hydrogenating the azidodimesylate in ethanol at ambient temperature,k) heating the resulting product in ethanol in the presence of sodium acetate to give a tetracyclic pyrrolizidine, andl) removing the acetonide protecting groups of the tetracyclic pyrrolizidine by acid hydrolysis to give (1S,2R,6R,7S)-1,2,6,7-tetrahydroxypyrrolizidine.
摘要翻译：公开了作为糖苷酶的抑制剂的新型二环四羟甲基化的吡咯烷子。优选的抑制剂是（1S，2R，6R，7S）-1,2,6,7-四羟基吡咯烷啶。由D-甘油基-D-庚内酰-1,4-内酯合成并利用新的中间体化合物7-O-叔丁基二苯基甲硅烷基-2,3：5,6-二-O-异亚丙基-D- 甘油基-D-庚内酰-1,4-内酯和（1S，2R，6R，7S）-1,2：6,7-二-O-异亚丙基-1,2,6,7-四羟基吡咯烷脒，为如下：a）使D-甘油基-D-庚内酰-1,4-内酯与2,2-二甲氧基丙烷反应，得到完全保护的内酯，b）选择性地除去C-6,7上的丙酮化合物，得到C -2,3保护的庚内酯，c）使C-2,3保护的内酯与甲硅烷基封闭剂反应以保护伯羟基并得到C-2,3,7保护的内酯，d）使保护的内酯与2 的2-二甲氧基丙烷，以提供完全保护的内酯，e）使完全保护的内酯与氟离子反应以在C7处裂解，从而提供进入环中的氮并获得伯醇，f）用三氟甲磺酸酯化伯醇得到三氟甲磺酸酯，g）使三氟甲磺酸酯反应用叠氮化物离子，得到叠氮内酯，h）还原叠氮内酯得到叠氮基二醇，i）叠氮二醇与甲磺酰氯反应，得到二硫代二季铵盐，j）在环境温度下催化氢化叠氮二季戊酸酯在乙醇中，k）加热得到的产物在乙酸乙酯中，在乙酸钠存在下反应，得到四环吡咯烷啶，并且l）通过酸水解除去四环吡咯烷子酮的丙酮化合物保护基，得到（1S，2R，6R，7S）-1,2,6,7-四羟基吡咯烷。

8. 发明申请

US20180305313A1 COLORED PHOTOSENSITIVE RESIN COMPOSITION AND LIGHT SHIELDING SPACER PREPARED THEREFROM 审中-公开
公开(公告)号：US20180305313A1
公开(公告)日：2018-10-25
申请号：US15769875
申请日：2016-09-23
申请人： Rohm and Haas Electronic Materials Korea Ltd.
发明人： Seok-Bong Park , Gyung-Sik Choi , Yeonok Kim
IPC分类号： C07D209/82 , C07D251/12 , C07D317/10 , C07D405/12 , G03F7/00 , G03F7/029 , G03F7/031 , G03F7/038 , G03F7/105
CPC分类号： C07D209/82 , C07D251/12 , C07D317/10 , C07D405/12 , G03F7/0007 , G03F7/029 , G03F7/031 , G03F7/0388 , G03F7/105
摘要： Disclosed herein is a colored photosensitive resin composition including a copolymer, an epoxy resin compound or a compound derived therefrom, a polymerizable compound, a photoinitiator, and a colorant, wherein the photoinitiator includes an oxime compound and a triazine compound. The composition, when formed into a cured film, may facilitate the fabrication of necessary height difference and satisfy the requirements of sensitivity and an exposure margin for light shielding spacers, and, thus, is useful as a material for manufacturing a light shielding spacer such as a black column spacer used in various electronic parts including the panels of an LCD and an OLED display.

9. 发明授权

US09458125B2 Octahydro binaphthyl-based chiral compound-containing liquid-crystal composition and optical element 有权
标题翻译：含八氢联萘基手性化合物的液晶组合物和光学元件
公开(公告)号：US09458125B2
公开(公告)日：2016-10-04
申请号：US14649917
申请日：2013-12-12
申请人： JNC CORPORATION , JNC PETROCHEMICAL CORPORATION
发明人： Koki Sago , Shin-Ichi Yamamoto
IPC分类号： G02F1/1333 , C07D317/10 , C07D319/06 , C07D321/00 , G02F1/137 , C09K19/58 , C07D239/26 , C09K19/54 , C07D309/04 , C07D317/12 , C07D405/12 , C07D407/12 , C07D493/18 , C09K19/20 , C09K19/32 , C09K19/34 , C09K19/04
CPC分类号： C07D317/10 , C07D239/26 , C07D309/04 , C07D317/12 , C07D319/06 , C07D321/00 , C07D405/12 , C07D407/12 , C07D493/18 , C09K19/20 , C09K19/34 , C09K19/542 , C09K19/586 , C09K19/588 , C09K2019/0411 , C09K2019/0466 , C09K2019/323 , C09K2019/325 , C09K2019/3422 , C09K2019/3427 , C09K2019/343 , C09K2019/3433 , G02F1/137 , G02F2001/13793
摘要： A liquid-crystal composition is composed of at least one chiral compound represented by general formula (K1) or (K2) and at least one achiral liquid-crystal component: (wherein, in formulas (K1) and (K2), Rk1 is, for example, alkyl having 1 to 5 carbons, Rk2 is, for example, alkyl having 1 to 20 carbons, ring Ak1 is, for example, 1,4-phenylene, Xk1 is, for example, a single bond, Yk1 is, for example, —(CH2)n—, n is an integer from 0 to 20, Zk1 is, for example, a single bond, mk1 is, for example, an integer from 2 to 4, and nk1 and nk2 are, for example, an integer from 0 to 2).

10. 发明申请

US20120295874A1 COFERONS AND METHODS OF MAKING AND USING THEM 有权
标题翻译：制作和使用它们的公司及方法
公开(公告)号：US20120295874A1
公开(公告)日：2012-11-22
申请号：US13500857
申请日：2010-10-07
申请人： Francis Barany , Maneesh Pingle , Sarah Filippa Giardina , Donald Bergstrom , Lee Daniel Arnold
发明人： Francis Barany , Maneesh Pingle , Sarah Filippa Giardina , Donald Bergstrom , Lee Daniel Arnold
IPC分类号： A61K31/69 , G01N33/566 , A61K31/397 , A61K31/506 , A61K31/505 , A61K31/454 , A61K31/415 , A61K31/357 , C07F5/02 , C07D403/14 , C07D239/42 , C07D401/12 , C07D231/38 , C07D207/24 , C07D205/04 , C07D319/12 , C07D413/14 , A61K31/4015 , G01N33/53
CPC分类号： C07D319/14 , C07D207/12 , C07D207/24 , C07D209/52 , C07D239/42 , C07D239/54 , C07D241/36 , C07D263/20 , C07D295/18 , C07D307/80 , C07D317/10 , C07D317/44 , C07D319/12 , C07D403/06 , C07D403/14 , C07D405/14 , C07D413/06 , C07D471/14 , C07D491/04 , C07D491/10 , C07D491/14 , C07F5/025 , C40B30/04
摘要： The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes one or more pharmacophores which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the pharmacophore. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to the pharmacophore.
摘要翻译：本发明涉及可用于制备治疗化合物的单体。单体包括一个或多个药效团，其可以以小于300μM的解离常数潜在地结合靶分子，并连接到药效团。连接体元件具有小于500道尔顿的分子量，通过连接器直接或间接连接到药效团。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式